MedTrace Logo

The ACC Preclinical Research Platform for Precision Oncology

NCT06339541 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2024-04-01

No results posted yet for this study

Summary

The ACC Preclinical Research Platform for Precision Oncology is a retrospective and prospective observational study focused on the implementation and validation of the application of PDCM (Patient Derived Cancer Models) generated from tissues or cells of patients with neoplastic disease, as a tool to improve molecular and biological knowledge of tumours and to test the efficacy and sensitivity of pharmacological treatments.

Conditions

Sponsors & Collaborators

  • Alleanza Contro il Cancro

    collaborator OTHER

  • Fondazione del Piemonte per l'Oncologia

    lead OTHER

Principal Investigators

  • Enzo Medico, MD · Fondazione del Piemonte per l'Oncologia

Eligibility

Min Age
14 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-05
Primary Completion
2024-06-01
Completion
2024-12-01

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06339541 on ClinicalTrials.gov